On the recordMay 23, 2016
I thank Ms. Sinema and Mr. Fitzpatrick for their fine work on this piece of legislation, which basically is a commonsense piece of legislation to help a lot of our small, biotech companies to be able to do a better job of managing their own funds. I yield back the balance of my time. The SPEAKER pro tempore (Mr. Duncan of Tennessee). The question is on the motion offered by the gentleman from Missouri (Mr. Luetkemeyer) that the House suspend the rules and pass the bill, H.R. 4139. The question was taken; and (two-thirds being in the affirmative) the rules were suspended and the bill was passed. A motion to reconsider was laid on the table. ____________________
